Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Open-market buy 10% owner bought 1,010,000 shares at $19.26 ($19,452,600)
  2. 4 Planned sale Chief Operating Officer sold 12,437 shares at $19.12 ($237,795)
  3. 4 Returned to the company General Counsel returned 2,892 shares (to the company)
  4. 4 Planned sale Chief Operating Officer sold 12,563 shares at $19.35 ($243,094)
  5. 4 Returned to the company President returned 4,820 shares (to the company)
  6. 4 Returned to the company Chief Executive Officer returned 8,762 shares (to the company)
  7. 4 Grant or award Director acquired 6,800 shares (grant or award)
  8. 4 Grant or award Director acquired 6,800 shares (grant or award)
  9. 4 Grant or award Director acquired 6,800 shares (grant or award)
  10. 4 Grant or award Director acquired 6,800 shares (grant or award)
  11. 4 Grant or award Director acquired 6,800 shares (grant or award)
  12. 4 Grant or award Director acquired 6,800 shares (grant or award)
  13. 4 Grant or award Director acquired 6,800 shares (grant or award)
  14. 4 Planned sale Chief Financial Officer sold 4,049 shares at $20.04 ($81,142)
  15. 4 Open-market sale Chief Operating Officer sold 8,729 shares at $16.81 ($146,734)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Operating Officer sold 1,900 shares at an average $23.53 ($44,700)
  18. 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 34,000 shares (grant or award)
  20. 4 Grant or award General Counsel acquired 34,000 shares (grant or award)

Page 7 of 15 · 290 filings